Found 18 search result(s) for Lancet.
4.1 Ronald Desrosiers — The Origin of SIVmac: Non-human Primate Models for HIV
(HIV/AIDS Research: Its History & Future Meeting)
... our competitors 00:04:00 at Davis, California published a similar report in Lancet. (9) I, of course, derived great joy in pointing out wherever I ...
Apr 27, 2021
... our competitors 00:04:00 at Davis, California published a similar report in Lancet. (9) I, of course, derived great joy in pointing out wherever I ...
Apr 27, 2021
1.7 Max Essex — From Feline Leukemia Virus to AIDS in Africa
(HIV/AIDS Research: Its History & Future Meeting)
... African Green Monkeys and Recognition of STLVIII Viral Proteins by AIDS and Related Sera.” The Lancet 325, no. 8441 (June 8, 1985): 1330–32. doi:10.1016/S01406736 ...
Apr 27, 2021
... African Green Monkeys and Recognition of STLVIII Viral Proteins by AIDS and Related Sera.” The Lancet 325, no. 8441 (June 8, 1985): 1330–32. doi:10.1016/S01406736 ...
Apr 27, 2021
2.5 Françoise Barré-Sinoussi — Discovery of HIV
(HIV/AIDS Research: Its History & Future Meeting)
... New Lymphotropic Retrovirus from Two Siblings with Haemophilia B, One with AIDS.” The Lancet 323, no. 8380 (April 7, 1984): 753–57. doi:10.1016/S01406736 ...
Apr 27, 2021
... New Lymphotropic Retrovirus from Two Siblings with Haemophilia B, One with AIDS.” The Lancet 323, no. 8380 (April 7, 1984): 753–57. doi:10.1016/S01406736 ...
Apr 27, 2021
8.1 John Mellors — MACS and Beyond: Epidemiology, Viremia and Pathogenesis
(HIV/AIDS Research: Its History & Future Meeting)
... 10,000 copies was the most powerful predictor of AIDS. We sent the paper off, and The Lancet 00:03:00 editor wrote back to me and said, "I can't ...
Apr 27, 2021
... 10,000 copies was the most powerful predictor of AIDS. We sent the paper off, and The Lancet 00:03:00 editor wrote back to me and said, "I can't ...
Apr 27, 2021
1.4 Robin Weiss — Retrovirus History and Early Searches for Human Retroviruses
(HIV/AIDS Research: Its History & Future Meeting)
... deThé. “Antibodies to Human TLymphotropic Virus TypeI in Patients with Tropical Spastic Paraparesis.” The Lancet, Originally published as Volume 2, Issue 8452, 326, no. 8452 (August 24 ...
Apr 27, 2021
... deThé. “Antibodies to Human TLymphotropic Virus TypeI in Patients with Tropical Spastic Paraparesis.” The Lancet, Originally published as Volume 2, Issue 8452, 326, no. 8452 (August 24 ...
Apr 27, 2021
3.1 Marty St. Clair: Discovery of AZT as the First Anti-HIV Drug
(HIV/AIDS Research: Its History & Future Meeting)
... safety study July 3rd, 1985. The first 19 patients were reported in Lancet March 15th 00:19:00 1986. (3) We found out ...
Apr 27, 2021
... safety study July 3rd, 1985. The first 19 patients were reported in Lancet March 15th 00:19:00 1986. (3) We found out ...
Apr 27, 2021
6.4 Barton Haynes — Development of HIV Vaccine: Steps and Missteps
(HIV/AIDS Research: Its History & Future Meeting)
... published in the New England Journal (7). Then a follow up from Merlin Robb in The Lancet that showed—Someone was talking earlier about the evanescent nature of the antibody response due ...
Apr 27, 2021
... published in the New England Journal (7). Then a follow up from Merlin Robb in The Lancet that showed—Someone was talking earlier about the evanescent nature of the antibody response due ...
Apr 27, 2021
6.6 Robert Redfield — The PEPFAR Program to Treat HIV in Africa
(HIV/AIDS Research: Its History & Future Meeting)
... Botswana, which was significant, 45% to less than 1%. The recent data that they published in Lancet showed that he's almost brought the country to the 1999 goals, and really it's a real ...
Apr 27, 2021
... Botswana, which was significant, 45% to less than 1%. The recent data that they published in Lancet showed that he's almost brought the country to the 1999 goals, and really it's a real ...
Apr 27, 2021
8.5 Sharon Lewin — Research to a Cure: A Possible Goal?
(HIV/AIDS Research: Its History & Future Meeting)
... Suppressive Antiretroviral Therapy: A Phase 1/2, Single Group, Clinical Trial.” The Lancet HIV 1, no. 1 (October 1, 2014): e13–21. doi:10.1016 ...
Apr 27, 2021
... Suppressive Antiretroviral Therapy: A Phase 1/2, Single Group, Clinical Trial.” The Lancet HIV 1, no. 1 (October 1, 2014): e13–21. doi:10.1016 ...
Apr 27, 2021
3.2 Samuel Broder: The First Clinical Trials of Antiretroviral Drugs
(HIV/AIDS Research: Its History & Future Meeting)
... Azido3’Deoxythymidine, an Inhibitor of HTLVIII/LAV Replication, to Patients with AIDS or AIDSRelated Complex.” The Lancet, Originally published as Volume 1, Issue 8481, 327, no. 8481 (March 15 ...
Apr 27, 2021
... Azido3’Deoxythymidine, an Inhibitor of HTLVIII/LAV Replication, to Patients with AIDS or AIDSRelated Complex.” The Lancet, Originally published as Volume 1, Issue 8481, 327, no. 8481 (March 15 ...
Apr 27, 2021
6.1 Sharon Hillier — Development and Application of Pre-exposure Prophylaxis (PrEP)
(HIV/AIDS Research: Its History & Future Meeting)
... al. “HIV1 Infection Associated with Abnormal Vaginal Flora Morphology and Bacterial Vaginosis.” The Lancet 350, no. 9077 (August 23, 1997): 546–50. doi:10.1016/S01406736 ...
Apr 27, 2021
... al. “HIV1 Infection Associated with Abnormal Vaginal Flora Morphology and Bacterial Vaginosis.” The Lancet 350, no. 9077 (August 23, 1997): 546–50. doi:10.1016/S01406736 ...
Apr 27, 2021
2.4 Robert Gallo — Discoveries of Human Retrovirus, Their Linkage to Disease as Causative Agents & Preparation for the Future
(HIV/AIDS Research: Its History & Future Meeting)
... other papers. (15, 16, 17) And this came out three weeks later in Lancet. (18) The key thing is a doubleblind study, and 100% of AIDS sera scored positive ...
Apr 27, 2021
... other papers. (15, 16, 17) And this came out three weeks later in Lancet. (18) The key thing is a doubleblind study, and 100% of AIDS sera scored positive ...
Apr 27, 2021
6.7 Salim Abdool Karim — Stopping the Spread of HIV in Developing Countries
(HIV/AIDS Research: Its History & Future Meeting)
... Networks and Risk of HIV Infection in KwaZuluNatal, South Africa: A CommunityWide Phylogenetic Study.” The Lancet HIV 4, no. 1 (January 2017): e41–50. doi:10.1016/S23523018 ...
Apr 27, 2021
... Networks and Risk of HIV Infection in KwaZuluNatal, South Africa: A CommunityWide Phylogenetic Study.” The Lancet HIV 4, no. 1 (January 2017): e41–50. doi:10.1016/S23523018 ...
Apr 27, 2021
8.2 David Ho — Unraveling of HIV Dynamics In Vivo
(HIV/AIDS Research: Its History & Future Meeting)
... Clearance of HIV1 and Hepatitis C Virus Assessed by Large Volume Plasma Apheresis.” The Lancet 354, no. 9192 (November 20, 1999): 1782–85. doi:10.1016/S01406736 ...
Apr 27, 2021
... Clearance of HIV1 and Hepatitis C Virus Assessed by Large Volume Plasma Apheresis.” The Lancet 354, no. 9192 (November 20, 1999): 1782–85. doi:10.1016/S01406736 ...
Apr 27, 2021
3.3 Douglas Richman: Antiviral Drug Resistance and Combination ART
(HIV/AIDS Research: Its History & Future Meeting)
... IMP2437 https://doi.org/10.3851/IMP2437. Aboulker, JeanPierre, and AnnMarie Swart. “Preliminary Analysis of the Concorde Trial.” The Lancet, Originally published as Volume 1, Issue 8849, 341, no. 8849 (April 3 ...
Apr 27, 2021
... IMP2437 https://doi.org/10.3851/IMP2437. Aboulker, JeanPierre, and AnnMarie Swart. “Preliminary Analysis of the Concorde Trial.” The Lancet, Originally published as Volume 1, Issue 8849, 341, no. 8849 (April 3 ...
Apr 27, 2021
3.6 John C. Martin — Making it Simpler: A Single Pill to Treat HIV
(HIV/AIDS Research: Its History & Future Meeting)
... Load, and Yearly New HIV Diagnoses in British Columbia, Canada: A PopulationBased Study.” The Lancet 376, no. 9740 (August 14, 2010): 532–39. doi:10.1016/S01406736 ...
Apr 27, 2021
... Load, and Yearly New HIV Diagnoses in British Columbia, Canada: A PopulationBased Study.” The Lancet 376, no. 9740 (August 14, 2010): 532–39. doi:10.1016/S01406736 ...
Apr 27, 2021
8.4 Robert Siliciano — The Challenge of the HIV Reservoir
(HIV/AIDS Research: Its History & Future Meeting)
... Landay, et al. “Depletion of Latent HIV1 Infection in Vivo: A ProofofConcept Study.” The Lancet 366, no. 9485 (August 13, 2005): 549–55. doi:10.1016/S01406736 ...
Apr 27, 2021
... Landay, et al. “Depletion of Latent HIV1 Infection in Vivo: A ProofofConcept Study.” The Lancet 366, no. 9485 (August 13, 2005): 549–55. doi:10.1016/S01406736 ...
Apr 27, 2021
Session 7: Prospects for an HIV Vaccine
(HIV/AIDS Research: Its History & Future Meeting)
... South Africa from 1997 to 2012: Second National Burden of Disease Study.” The Lancet Global Health 4, no. 9 (September 1, 2016): e642–53. doi ...
Apr 27, 2021
... South Africa from 1997 to 2012: Second National Burden of Disease Study.” The Lancet Global Health 4, no. 9 (September 1, 2016): e642–53. doi ...
Apr 27, 2021